Hologic introduces QDR 4000 scanner
Bone densitometry firm Hologic (Hall A, #3447) will be breathing easier at its RSNA booth since the Health Care Financing Administration last month published revised Medicare reimbursement rates that correct misprinted figures released earlier this year.
Bone densitometry firm Hologic (Hall A, #3447) will be breathing easier at its RSNA booth since the Health Care Financing Administration last month published revised Medicare reimbursement rates that correct misprinted figures released earlier this year. The misprinted numbers would have sharply reduced Medicare payments for axial bone densitometry and caused many providers to postpone purchases of axial scanners over the summer (SCAN 11/12/97).
On the new product front, the Waltham, MA, company will debut QDR 4000, the newest member of its QDR family of dual-energy x-ray absorptiometry (DEXA) scanners. QDR 4000 is designed to offer the functionality of a full-featured DEXA scanner in a compact and low-cost package, according to Wade Fox, director of marketing.
Hologic will also feature Sahara, a waterless ultrasound densitometer that is awaiting final FDA clearance.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
